Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane
• We describe prospective immunomonitoring of BC patients on everolimus exemestane. • The baseline percentage of CD4+ effector cells was predictive of non-response. • The baseline percentage of NKT-cells was predictive of pulmonary toxicity.
Gespeichert in:
| Autor*in: |
Willemsen, Annelieke E.C.A.B. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: International immunopharmacology - Laupland, Kevin B. ELSEVIER, 2022, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:93 ; year:2021 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.intimp.2021.107404 |
|---|
| Katalog-ID: |
ELV053323076 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV053323076 | ||
| 003 | DE-627 | ||
| 005 | 20230624193831.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.intimp.2021.107404 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001878.pica |
| 035 | |a (DE-627)ELV053323076 | ||
| 035 | |a (ELSEVIER)S1567-5769(21)00040-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.75 |2 bkl | ||
| 100 | 1 | |a Willemsen, Annelieke E.C.A.B. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane |
| 264 | 1 | |c 2021 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • We describe prospective immunomonitoring of BC patients on everolimus exemestane. • The baseline percentage of CD4+ effector cells was predictive of non-response. • The baseline percentage of NKT-cells was predictive of pulmonary toxicity. | ||
| 650 | 7 | |a Drug-induced lung injury |2 Elsevier | |
| 650 | 7 | |a Interstitial lung disease |2 Elsevier | |
| 650 | 7 | |a Everolimus |2 Elsevier | |
| 650 | 7 | |a Immunomonitoring |2 Elsevier | |
| 650 | 7 | |a Response prediction |2 Elsevier | |
| 700 | 1 | |a He, Xuehui |4 oth | |
| 700 | 1 | |a van Cranenbroek, Bram |4 oth | |
| 700 | 1 | |a de Jong, Paul C. |4 oth | |
| 700 | 1 | |a de Boer, Maaike |4 oth | |
| 700 | 1 | |a Joosten, Irma |4 oth | |
| 700 | 1 | |a Koenen, Hans J.P.M. |4 oth | |
| 700 | 1 | |a van Herpen, Carla M.L. |4 oth | |
| 700 | 1 | |a Gerritsen, Winald R. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Laupland, Kevin B. ELSEVIER |t International immunopharmacology |d 2022 |g Amsterdam [u.a.] |w (DE-627)ELV00785823X |
| 773 | 1 | 8 | |g volume:93 |g year:2021 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.intimp.2021.107404 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.75 |j Infektionskrankheiten |j parasitäre Krankheiten |x Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 93 |j 2021 |h 0 | ||
| author_variant |
a e w ae aew |
|---|---|
| matchkey_str |
willemsenanneliekeecabhexuehuivancranenb:2021----:aeiefetrelpeitepnenntelpeitumnrtxctiavnebescnepte |
| hierarchy_sort_str |
2021 |
| bklnumber |
44.75 |
| publishDate |
2021 |
| allfields |
10.1016/j.intimp.2021.107404 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001878.pica (DE-627)ELV053323076 (ELSEVIER)S1567-5769(21)00040-0 DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Willemsen, Annelieke E.C.A.B. verfasserin aut Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We describe prospective immunomonitoring of BC patients on everolimus exemestane. • The baseline percentage of CD4+ effector cells was predictive of non-response. • The baseline percentage of NKT-cells was predictive of pulmonary toxicity. Drug-induced lung injury Elsevier Interstitial lung disease Elsevier Everolimus Elsevier Immunomonitoring Elsevier Response prediction Elsevier He, Xuehui oth van Cranenbroek, Bram oth de Jong, Paul C. oth de Boer, Maaike oth Joosten, Irma oth Koenen, Hans J.P.M. oth van Herpen, Carla M.L. oth Gerritsen, Winald R. oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:93 year:2021 pages:0 https://doi.org/10.1016/j.intimp.2021.107404 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 93 2021 0 |
| spelling |
10.1016/j.intimp.2021.107404 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001878.pica (DE-627)ELV053323076 (ELSEVIER)S1567-5769(21)00040-0 DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Willemsen, Annelieke E.C.A.B. verfasserin aut Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We describe prospective immunomonitoring of BC patients on everolimus exemestane. • The baseline percentage of CD4+ effector cells was predictive of non-response. • The baseline percentage of NKT-cells was predictive of pulmonary toxicity. Drug-induced lung injury Elsevier Interstitial lung disease Elsevier Everolimus Elsevier Immunomonitoring Elsevier Response prediction Elsevier He, Xuehui oth van Cranenbroek, Bram oth de Jong, Paul C. oth de Boer, Maaike oth Joosten, Irma oth Koenen, Hans J.P.M. oth van Herpen, Carla M.L. oth Gerritsen, Winald R. oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:93 year:2021 pages:0 https://doi.org/10.1016/j.intimp.2021.107404 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 93 2021 0 |
| allfields_unstemmed |
10.1016/j.intimp.2021.107404 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001878.pica (DE-627)ELV053323076 (ELSEVIER)S1567-5769(21)00040-0 DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Willemsen, Annelieke E.C.A.B. verfasserin aut Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We describe prospective immunomonitoring of BC patients on everolimus exemestane. • The baseline percentage of CD4+ effector cells was predictive of non-response. • The baseline percentage of NKT-cells was predictive of pulmonary toxicity. Drug-induced lung injury Elsevier Interstitial lung disease Elsevier Everolimus Elsevier Immunomonitoring Elsevier Response prediction Elsevier He, Xuehui oth van Cranenbroek, Bram oth de Jong, Paul C. oth de Boer, Maaike oth Joosten, Irma oth Koenen, Hans J.P.M. oth van Herpen, Carla M.L. oth Gerritsen, Winald R. oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:93 year:2021 pages:0 https://doi.org/10.1016/j.intimp.2021.107404 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 93 2021 0 |
| allfieldsGer |
10.1016/j.intimp.2021.107404 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001878.pica (DE-627)ELV053323076 (ELSEVIER)S1567-5769(21)00040-0 DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Willemsen, Annelieke E.C.A.B. verfasserin aut Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We describe prospective immunomonitoring of BC patients on everolimus exemestane. • The baseline percentage of CD4+ effector cells was predictive of non-response. • The baseline percentage of NKT-cells was predictive of pulmonary toxicity. Drug-induced lung injury Elsevier Interstitial lung disease Elsevier Everolimus Elsevier Immunomonitoring Elsevier Response prediction Elsevier He, Xuehui oth van Cranenbroek, Bram oth de Jong, Paul C. oth de Boer, Maaike oth Joosten, Irma oth Koenen, Hans J.P.M. oth van Herpen, Carla M.L. oth Gerritsen, Winald R. oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:93 year:2021 pages:0 https://doi.org/10.1016/j.intimp.2021.107404 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 93 2021 0 |
| allfieldsSound |
10.1016/j.intimp.2021.107404 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001878.pica (DE-627)ELV053323076 (ELSEVIER)S1567-5769(21)00040-0 DE-627 ger DE-627 rakwb eng 610 VZ 44.75 bkl Willemsen, Annelieke E.C.A.B. verfasserin aut Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We describe prospective immunomonitoring of BC patients on everolimus exemestane. • The baseline percentage of CD4+ effector cells was predictive of non-response. • The baseline percentage of NKT-cells was predictive of pulmonary toxicity. Drug-induced lung injury Elsevier Interstitial lung disease Elsevier Everolimus Elsevier Immunomonitoring Elsevier Response prediction Elsevier He, Xuehui oth van Cranenbroek, Bram oth de Jong, Paul C. oth de Boer, Maaike oth Joosten, Irma oth Koenen, Hans J.P.M. oth van Herpen, Carla M.L. oth Gerritsen, Winald R. oth Enthalten in Elsevier Science Laupland, Kevin B. ELSEVIER International immunopharmacology 2022 Amsterdam [u.a.] (DE-627)ELV00785823X volume:93 year:2021 pages:0 https://doi.org/10.1016/j.intimp.2021.107404 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.75 Infektionskrankheiten parasitäre Krankheiten Medizin VZ AR 93 2021 0 |
| language |
English |
| source |
Enthalten in International immunopharmacology Amsterdam [u.a.] volume:93 year:2021 pages:0 |
| sourceStr |
Enthalten in International immunopharmacology Amsterdam [u.a.] volume:93 year:2021 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Infektionskrankheiten parasitäre Krankheiten |
| institution |
findex.gbv.de |
| topic_facet |
Drug-induced lung injury Interstitial lung disease Everolimus Immunomonitoring Response prediction |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
International immunopharmacology |
| authorswithroles_txt_mv |
Willemsen, Annelieke E.C.A.B. @@aut@@ He, Xuehui @@oth@@ van Cranenbroek, Bram @@oth@@ de Jong, Paul C. @@oth@@ de Boer, Maaike @@oth@@ Joosten, Irma @@oth@@ Koenen, Hans J.P.M. @@oth@@ van Herpen, Carla M.L. @@oth@@ Gerritsen, Winald R. @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV00785823X |
| dewey-sort |
3610 |
| id |
ELV053323076 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV053323076</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624193831.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.intimp.2021.107404</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001878.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV053323076</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1567-5769(21)00040-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.75</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Willemsen, Annelieke E.C.A.B.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• We describe prospective immunomonitoring of BC patients on everolimus exemestane. • The baseline percentage of CD4+ effector cells was predictive of non-response. • The baseline percentage of NKT-cells was predictive of pulmonary toxicity.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug-induced lung injury</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Interstitial lung disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Everolimus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunomonitoring</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Response prediction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">He, Xuehui</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">van Cranenbroek, Bram</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de Jong, Paul C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de Boer, Maaike</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Joosten, Irma</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koenen, Hans J.P.M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">van Herpen, Carla M.L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gerritsen, Winald R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Laupland, Kevin B. ELSEVIER</subfield><subfield code="t">International immunopharmacology</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00785823X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:93</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.intimp.2021.107404</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.75</subfield><subfield code="j">Infektionskrankheiten</subfield><subfield code="j">parasitäre Krankheiten</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">93</subfield><subfield code="j">2021</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Willemsen, Annelieke E.C.A.B. |
| spellingShingle |
Willemsen, Annelieke E.C.A.B. ddc 610 bkl 44.75 Elsevier Drug-induced lung injury Elsevier Interstitial lung disease Elsevier Everolimus Elsevier Immunomonitoring Elsevier Response prediction Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane |
| authorStr |
Willemsen, Annelieke E.C.A.B. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV00785823X |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.75 bkl Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane Drug-induced lung injury Elsevier Interstitial lung disease Elsevier Everolimus Elsevier Immunomonitoring Elsevier Response prediction Elsevier |
| topic |
ddc 610 bkl 44.75 Elsevier Drug-induced lung injury Elsevier Interstitial lung disease Elsevier Everolimus Elsevier Immunomonitoring Elsevier Response prediction |
| topic_unstemmed |
ddc 610 bkl 44.75 Elsevier Drug-induced lung injury Elsevier Interstitial lung disease Elsevier Everolimus Elsevier Immunomonitoring Elsevier Response prediction |
| topic_browse |
ddc 610 bkl 44.75 Elsevier Drug-induced lung injury Elsevier Interstitial lung disease Elsevier Everolimus Elsevier Immunomonitoring Elsevier Response prediction |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
x h xh c b v cb cbv j p c d jpc jpcd b m d bm bmd i j ij h j k hj hjk h c m v hcm hcmv w r g wr wrg |
| hierarchy_parent_title |
International immunopharmacology |
| hierarchy_parent_id |
ELV00785823X |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
International immunopharmacology |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV00785823X |
| title |
Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane |
| ctrlnum |
(DE-627)ELV053323076 (ELSEVIER)S1567-5769(21)00040-0 |
| title_full |
Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane |
| author_sort |
Willemsen, Annelieke E.C.A.B. |
| journal |
International immunopharmacology |
| journalStr |
International immunopharmacology |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Willemsen, Annelieke E.C.A.B. |
| container_volume |
93 |
| class |
610 VZ 44.75 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Willemsen, Annelieke E.C.A.B. |
| doi_str_mv |
10.1016/j.intimp.2021.107404 |
| dewey-full |
610 |
| title_sort |
baseline effector cells predict response and nkt cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane |
| title_auth |
Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane |
| abstract |
• We describe prospective immunomonitoring of BC patients on everolimus exemestane. • The baseline percentage of CD4+ effector cells was predictive of non-response. • The baseline percentage of NKT-cells was predictive of pulmonary toxicity. |
| abstractGer |
• We describe prospective immunomonitoring of BC patients on everolimus exemestane. • The baseline percentage of CD4+ effector cells was predictive of non-response. • The baseline percentage of NKT-cells was predictive of pulmonary toxicity. |
| abstract_unstemmed |
• We describe prospective immunomonitoring of BC patients on everolimus exemestane. • The baseline percentage of CD4+ effector cells was predictive of non-response. • The baseline percentage of NKT-cells was predictive of pulmonary toxicity. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane |
| url |
https://doi.org/10.1016/j.intimp.2021.107404 |
| remote_bool |
true |
| author2 |
He, Xuehui van Cranenbroek, Bram de Jong, Paul C. de Boer, Maaike Joosten, Irma Koenen, Hans J.P.M. van Herpen, Carla M.L. Gerritsen, Winald R. |
| author2Str |
He, Xuehui van Cranenbroek, Bram de Jong, Paul C. de Boer, Maaike Joosten, Irma Koenen, Hans J.P.M. van Herpen, Carla M.L. Gerritsen, Winald R. |
| ppnlink |
ELV00785823X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.intimp.2021.107404 |
| up_date |
2024-07-06T18:38:01.877Z |
| _version_ |
1803855941471305728 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV053323076</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624193831.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.intimp.2021.107404</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001878.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV053323076</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1567-5769(21)00040-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.75</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Willemsen, Annelieke E.C.A.B.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• We describe prospective immunomonitoring of BC patients on everolimus exemestane. • The baseline percentage of CD4+ effector cells was predictive of non-response. • The baseline percentage of NKT-cells was predictive of pulmonary toxicity.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug-induced lung injury</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Interstitial lung disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Everolimus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunomonitoring</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Response prediction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">He, Xuehui</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">van Cranenbroek, Bram</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de Jong, Paul C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de Boer, Maaike</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Joosten, Irma</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koenen, Hans J.P.M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">van Herpen, Carla M.L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gerritsen, Winald R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Laupland, Kevin B. ELSEVIER</subfield><subfield code="t">International immunopharmacology</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00785823X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:93</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.intimp.2021.107404</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.75</subfield><subfield code="j">Infektionskrankheiten</subfield><subfield code="j">parasitäre Krankheiten</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">93</subfield><subfield code="j">2021</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.402874 |